Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
425.00    57.00 (15.49%)
Bid:
425.00
Ask:
426.50
Spread: 1.50 (0.353%)
Market Cap: £1.16b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Trading Update

3 Sep 2020 07:00

RNS Number : 8744X
CMC Markets Plc
03 September 2020
 

3 September 2020

CMC Markets Plc

 

Trading Update

 

Continuing strong trading performance

CMC Markets Plc ("CMC" or the "Group"), a leading global provider of online trading and institutional ("B2B") platform technology solutions, today issues a trading update for the period from 1 July 2020 to 31 August 2020 (the "period").

The Group's consistently strong trading performance across the business has continued, with net operating income run rate for the two month period only slightly below Q1 2021, and client income has continued to be in excess of the same period in the prior year. In addition, client income retention has remained particularly strong and well in excess of the guidance of above 80%. The stockbroking business also continues to perform strongly.

 

As a result, the Board is confident that with the strong underlying performance and diversity of the business, FY 2021 net operating income will exceed the upper end of current market consensus1.

 

The higher revenue performance since the start of the financial year has been driven by existing clients trading more as well as the platform continuing to attract new clients. This has led to an increase in variable operating costs, predominantly driven by higher client onboarding costs and the more efficient acquisition of new clients.

 

The Group is also continuing its focus on investment in its technology to attract and retain clients and drive future growth.

 

Pre-close trading update

 

The Group is scheduled to release a H1 2021 pre-close trading update on Thursday 8 October 2020.

 

Enquiries

CMC Markets Plc investor.relations@cmcmarkets.com

Euan Marshall, Chief Financial Officer

 

Camarco +44 (0) 20 3757 4994

Geoffrey Pelham-Lane

Jennifer Renwick

 

Forward looking statements

 

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward looking statements to reflect events or developments occurring after the date such statements are published.

 

1 As at 2 September 2020, the Group's compiled Full Year 2021 consensus is as follows:

· Net operating income of £287.6 million, ranging from £282.4 million to £300.6 million; and

· Profit Before Tax of £122.8 million, ranging from £114.9 million to £137.0 million.

 

Notes to Editors

 

CMC Markets plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 13 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade up to 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAXNAEDXEEFA
Date   Source Headline
21st Nov 20247:05 amRNSDividend Declaration
21st Nov 20247:00 amRNSInterim Results
6th Nov 20243:29 pmRNSDirector/PDMR Shareholding
9th Oct 20249:42 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTrading Statement
9th Sep 20242:50 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:13 pmRNSDirector/PDMR Shareholding
15th Aug 20243:07 pmRNSDirector/PDMR Shareholding
14th Aug 20244:15 pmRNSDirector/PDMR Shareholding
12th Aug 20249:25 amRNSDirector/PDMR Shareholding
6th Aug 20244:59 pmRNSDirector/PDMR Shareholding
25th Jul 20241:20 pmRNSResult of AGM
25th Jul 20247:00 amRNSQ1 2025 Trading Update
24th Jul 202410:42 amRNSDirector/PDMR Shareholding
10th Jul 202412:12 pmRNSDirector/PDMR Shareholding
8th Jul 20245:11 pmRNSDirector/PDMR Shareholding
24th Jun 20245:45 pmRNSNotice of AGM
20th Jun 20247:03 amRNSDirectorate Change
20th Jun 20247:03 amRNSDividend Declaration
20th Jun 20247:00 amRNSFinal results for the year ended 31 March 2024
7th Jun 202410:49 amRNSDirector/PDMR Shareholding
8th May 20243:10 pmRNSDirector/PDMR Shareholding
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.